×
About 4,120 results

ALLMedicine™ Hyperkalemia Center

Research & Reviews  1,175 results

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
https://clinicaltrials.gov/ct2/show/NCT03528681

May 20th, 2022 - This study will be conducted in approximately 35 centers in China. Before patients are randomized to the double-blind phase, they will receive open-label ZS for 24 or 48 hours during the initial phase. It is expected that approximately 490 patient...

Spironolactone for Pulmonary Arterial Hypertension
https://clinicaltrials.gov/ct2/show/NCT01712620

May 20th, 2022 - INTRODUCTION: Pulmonary arterial hypertension (PAH) is a rare disorder associated with poor survival. Endothelial dysfunction resulting from 1) genetic susceptibility, and 2) a triggering stimulus that initiates pulmonary vascular injury, the two-...

Novel Use of Seraph-100™ Blood Purification Therapy in Heat Stroke.
https://doi.org/10.1093/milmed/usac124
Military Medicine; Miller MK, Spiller RE et. al.

May 16th, 2022 - The Seraph-100™ is a purification filter that blunts cytokine storm, providing a more favorable environment to establish immune homeostasis. We present a novel case of compassionate use of Seraph filter in a young, healthy active duty service memb...

Association of serum potassium with decline in residual kidney function in incident hem...
https://doi.org/10.1093/ndt/gfac181
Nephrology, Dialysis, Transplantation : Official Publicat... Arif Y, Wenziger C et. al.

May 14th, 2022 - Hyperkalemia is associated with kidney function decline in patients with non-dialysis dependent chronic kidney disease, but this relationship is unclear for residual kidney function among hemodialysis (HD) patients. We conducted a retrospective co...

An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interacti...
https://doi.org/10.2174/1573403X18666220511152330
Current Cardiology Reviews; Mohamed Pakkir Maideen N, Balasubramanian R et. al.

May 14th, 2022 - Hypertension is a leading cause of cardiovascular disease and chronic kidney disease resulting in premature death and disability. The Renin-Angiotensin-Aldosterone system (RAAS) blockers including Angiotensin Converting Enzyme (ACE) Inhibitors or ...

see more →

Guidelines  1 results

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood...
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.

Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...

see more →

Drugs  151 results see all →

Clinicaltrials.gov  48 results

Spironolactone for Pulmonary Arterial Hypertension
https://clinicaltrials.gov/ct2/show/NCT01712620

May 20th, 2022 - INTRODUCTION: Pulmonary arterial hypertension (PAH) is a rare disorder associated with poor survival. Endothelial dysfunction resulting from 1) genetic susceptibility, and 2) a triggering stimulus that initiates pulmonary vascular injury, the two-...

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
https://clinicaltrials.gov/ct2/show/NCT03528681

May 20th, 2022 - This study will be conducted in approximately 35 centers in China. Before patients are randomized to the double-blind phase, they will receive open-label ZS for 24 or 48 hours during the initial phase. It is expected that approximately 490 patient...

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
https://clinicaltrials.gov/ct2/show/NCT04524442

May 11th, 2022 - The study schedule for each patient consists of a screening period followed by an infusion day with an optional overnight in-clinic stay, and a follow up call 48h post infusion. Screening Phase: At screening, patient eligibility will be determined...

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
https://clinicaltrials.gov/ct2/show/NCT05348733

Apr 27th, 2022 - This is an observational study in people with chronic kidney disease (CKD) and type 2 diabetes (T2D) who will be receiving finerenone. Kidneys filter extra water and waste out of the blood and make urine. CKD is a long-term, progressive, decrease ...

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
https://clinicaltrials.gov/ct2/show/NCT03502031

Feb 1st, 2022 - NephroNet proposes to examine whether combining Spironolactone with maximal RAAS blockade will further reduce urinary protein at one year and whether prolonged therapy (24 months) is able to slow the decline in GFR. Because of combination MRA and ...

see more →

News  272 results

Potassium Abnormalities Boost Hospital Visits for Kidney Disease
https://www.medscape.com/viewarticle/972652

Apr 25th, 2022 - Patients with advanced chronic kidney disease (CKD) are at higher risk of hospitalization or requiring an emergency room (ER) visit in the short-term if they have abnormal potassium levels, a nationally representative cohort of US veterans with ad...

DIAMOND: Adding Patiromer Helps Optimize HF Meds, Foils Hyperkalemia
https://www.medscape.com/viewarticle/971616

Apr 5th, 2022 - Several of the core meds for patients with heart failure with reduced ejection fraction (HFrEF) come with a well-known risk of causing hyperkalemia, to which many clinicians respond by pulling back on dosing or withdrawing the culprit drug. But ac...

Fast Five Quiz: Emergency Management of Hyperkalemia
https://reference.medscape.com/viewarticle/970032

Mar 23rd, 2022 - Hyperkalemia is defined as a serum potassium concentration greater than approximately 5.0-5.5 mEq/L. Hyperkalemia can be difficult to diagnose clinically because symptoms may be vague or absent; many individuals are asymptomatic. When present, sym...

An Academic Hospitalist–Run Outpatient Paracentesis Clinic
https://www.mdedge.com/fedprac/article/252436/hospital-medicine/academic-hospitalist-run-outpatient-paracentesis-clinic
Lawrence D. Gerber, MD, Gaetan Sgro, MD et. al.

Mar 4th, 2022 - Cirrhosis is the most common cause of ascites in the United States. In patients with compensated cirrhosis, the 10-year probability of developing ascites is 47%.

Fast Five Quiz: Workup for Hyperkalemia
https://www.medscape.com/viewarticle/963569

Dec 9th, 2021 - Hyperkalemia is characterized by serum or plasma potassium levels above the upper limits of normal, typically greater than 5.0-5.5 mEq/L. Although patients with mild hyperkalemia are often asymptomatic, high levels of potassium may cause life-thre...

see more →

Patient Education  1 results see all →